Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Bradley Martin

TitleProfessor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPharmacy Practice, College of Pharmacy
DivisionPharmacy Practice
Address6251 ED III College of Public Health
220 UAMS Campus Dr.
Mail Slot # 522
Little Rock AR 72205
Phone501-603-1992
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R01DA054312     (THOMPSON, JOSEPH W)Sep 30, 2021 - Jul 31, 2024
    NIH
    Population-Based Analyses of Healthcare Utilization and Outcomes in Users of Medical Marijuana
    Role: Co-Investigator
    R21CA231180     (TEETER, BENJAMIN SAMUEL)Apr 1, 2019 - Mar 31, 2021
    NIH
    Improving HPV Vaccination using Implementation Strategies in Community Pharmacies
    Role: Co-Investigator
    R36DA046717     (HAYES, COREY J)Sep 30, 2018 - Aug 31, 2020
    NIH
    Impact of Opioid Dosing Strategies on Pain Scores and Adverse or Unintended Clinical Outcomes
    Role: Co-Investigator
    PTC2018     (MARTIN, BRADLEY)Apr 1, 2018 - May 31, 2019
    UAMS Intramural Grant (CTSA)
    Early Care Decisions and the Risk of Long-Term Opioid Use in Patients with Low Back Pain
    Role: Principal Investigator
    PTC2018-02     (MARTIN, BRADLEY)Apr 1, 2018 - May 31, 2019
    UAMS Intramural Grant (CTSA)
    Early Care Decisions and the Risk of Long-Term Opioid Use in Patients with Low Back Pain
    Role: Principal Investigator
    PTC2017     (MARTIN, BRADLEY)Apr 15, 2017 - May 31, 2018
    UAMS Intramural Grant (CTSA)
    Development, Validation, and Implementation of an Opioid Risk Prediction Tool
    Role: Principal Investigator
    PTC2017-04     (MARTIN, BRADLEY)Apr 15, 2017 - May 31, 2018
    UAMS Intramural Grant (CTSA)
    Development, Validation, and Implementation of an Opioid Risk Prediction Tool
    Role: Principal Investigator
    R01DA034627     (CURRAN, GEOFFREY M)Aug 1, 2014 - Apr 30, 2018
    NIH/Nat. Inst. on Drug Abuse - Pass Through: RTI, International
    Prescribers, Pharmacists, and the Opioid Dilemma
    Role: Co-Investigator
    R01DA030300     (HUDSON, TERESA JO)Aug 15, 2010 - Jul 31, 2015
    NIH
    Use and Abuse of Prescription Opioids Among OEF/OIF Veterans
    Role: Co-Investigator
    P20HS015878     (MARTIN, BRADLEY C)Jun 1, 2006 - May 31, 2008
    NIH
    Arkansas Consortium for Health Services Research
    Role: Principal Investigator
    P20HS015878     (MARTIN, BRADLEY)Jun 1, 2006 - May 31, 2008
    Agency for Healthcare Research & Quality
    UAMS Consortium for Health Service Research
    Role: Principal Investigator
    P20HS015878     (MARTIN, BRADLEY C)Jun 1, 2006 - May 31, 2008
    NIH
    Arkansas Consortium for Health Services Research
    Role: Principal Investigator
    UNCCH #5-48016     (MARTIN, BRADLEY)Jan 1, 2006 - Jun 30, 2008
    Robert Wood Johnson Foundation - Pass Through: University of North Carolina - Chapel Hill
    Duration Limitations and Adherence to Chronic Medication (Incoming Subc from UNC Chapel Hill)
    Role: Principal Investigator
    Task Order UA1     (MARTIN, BRADLEY)Jul 30, 2005 - Jul 29, 2006
    NOVARTIS Pharmaceuticals Corporation
    Utilization Patterns and Persistence of Antihormonal Therapies for Breast Cancer
    Role: Principal Investigator
    TaskOrderUA1     (MARTIN, BRADLEY)Jul 30, 2005 - Jul 29, 2006
    NOVARTIS Pharmaceuticals Corporation
    Utilization Patterns and Persistence of Antihormonal Therapies for Breast Cancer
    Role: Principal Investigator
    R03HS010815     (MARTIN, BRADLEY C)Jul 1, 2000 - Dec 31, 2002
    NIH
    ADVANCING RISK ADJUSTMENT FOR SCHIZOPHRENIA
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Smith AM, Peng C, Porter A, Martin BC. The role of prescribed controlled substance acquisition as potential triggers of opioid overdose: A case-crossover study. Int J Drug Policy. 2024 Oct 20; 134:104620. PMID: 39432978.
      View in: PubMed
    2. Martin BC, Thompson JW, Goudie A, Farnam C, Noori K, Stanley N, Daniels JR, Hudson TJ. A Statewide Examination of Medical Cannabis Purchasing Patterns in Arkansas Over the Three Years Immediately Following Legalization. Cannabis Cannabinoid Res. 2024 Sep 23. PMID: 39311804.
      View in: PubMed
    3. Hayes CJ, Martin BC, Hoggatt KJ, Cucciare MA, Hudson TJ, Gordon AJ. Average Daily Dose Trajectories for Episodes of Buprenorphine Treatment for Opioid Use Disorder. Subst Use Addctn J. 2024 Oct; 45(4):727-735. PMID: 39068539.
      View in: PubMed
    4. Mahashabde RV, Bhatti SA, Martin BC, Painter JT, Rodriguez A, Ying J, Li C. Immune checkpoint inhibitors as subsequent treatment in older adults with non-small cell lung cancer and synchronous brain metastases. Transl Lung Cancer Res. 2024 Jul 30; 13(7):1620-1634. PMID: 39118898.
      View in: PubMed
    5. Hayes CJ, Raciborski RA, Martin BC, Gordon AJ, Hudson TJ, Brown CC, Pro G, Cucciare MA. Are gaps in rates of retention on buprenorphine for treatment of opioid use disorder closing among veterans across different races and ethnicities? A retrospective cohort study. J Subst Use Addict Treat. 2024 Nov; 166:209461. PMID: 39067770.
      View in: PubMed
    6. Hayes CJ, Bin Noor N, Raciborski RA, Martin BC, Gordon AJ, Hoggatt KJ, Hudson T, Cucciare MA. Development and validation of machine-learning algorithms predicting retention, overdoses, and all-cause mortality among US military veterans treated with buprenorphine for opioid use disorder. J Addict Dis. 2024 06 30; 1-18. PMID: 38946144.
      View in: PubMed
    7. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations. Pain Med. 2024 Mar 01; 25(3):173-186. PMID: 38243702.
      View in: PubMed
    8. Koonce RM, Martin BC. The association between suspected long-COVID and stimulant prescribing in the United States. Psychiatry Res. 2024 Jan; 331:115686. PMID: 38142603.
      View in: PubMed
    9. Mahashabde R, Bhatti SA, Martin BC, Painter JT, Rodriguez A, Ying J, Li C. Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non-Small-Cell Lung Cancer and Synchronous Brain Metastases. JCO Oncol Pract. 2023 11; 19(11):1009-1019. PMID: 37729600.
      View in: PubMed
    10. Mavros MN, Johnson LA, Schootman M, Orcutt ST, Peng C, Martin BC. Adherence to Extended Venous Thromboembolism Prophylaxis and Outcomes After Complex Gastrointestinal Oncologic Surgery. Ann Surg Oncol. 2023 Sep; 30(9):5522-5531. PMID: 37338748.
      View in: PubMed
    11. Lakkad M, Martin B, Li C, Harrington S, Dayer L, Painter JT. Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors. Clin Breast Cancer. 2023 08; 23(6):598-619. PMID: 37328334.
      View in: PubMed
    12. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients. Clin J Pain. 2023 03 01; 39(3):107-118. PMID: 36728675.
      View in: PubMed
    13. Mahashabde RV, Shrikhande MA, Han X, Martin BC, ElHassan NO, Hayes CJ. Concordance of opioid exposure in all-payer claims databases with prescription drug monitoring program database using Arkansas as a case example. Health Serv Res. 2023 08; 58(4):938-947. PMID: 36519709.
      View in: PubMed
    14. Acharya M, Hayes CJ, Li C, Painter JT, Dayer L, Martin BC. Development of a potential opioid misuse measure from administrative dispensing data and contrasting opioid misuse among individuals on long-term tramadol, long-term short-acting hydrocodone or long-term short-acting oxycodone therapy in Arkansas. Curr Med Res Opin. 2022 11; 38(11):1947-1957. PMID: 36000252.
      View in: PubMed
    15. Hayes CJ, Koonce RM, Gressler LE, Hu B, Williams JS, Martin BC. Association between opioid therapy trajectories and potential opioid-related adverse health events. Pharmacoepidemiol Drug Saf. 2022 10; 31(10):1075-1090. PMID: 35695189.
      View in: PubMed
    16. Acharya M, Zorn KK, Simonson ME, Bimali M, Moore GW, Peng C, Martin BC. Statewide trends and factors associated with genetic testing for hereditary cancer risk in Arkansas 2013-2018. Hered Cancer Clin Pract. 2022 May 23; 20(1):19. PMID: 35606835.
      View in: PubMed
    17. Acharya M, Chopra D, Smith AM, Fritz JM, Martin BC. Associations Between Early Chiropractic Care and Physical Therapy on Subsequent Opioid Use Among Persons With Low Back Pain in Arkansas. J Chiropr Med. 2022 Jun; 21(2):67-76. PMID: 35774633.
      View in: PubMed
    18. Jain N, Martin BC, Dai J, Phadnis MA, Al-Hindi L, Shireman TI, Hedayati SS, Rasu RS, Mehta JL. Age Modifies Intracranial and Gastrointestinal Bleeding Risk from P2Y12 Inhibitors in Patients Receiving Dialysis. Kidney360. 2022 08 25; 3(8):1374-1383. PMID: 36176642.
      View in: PubMed
    19. Hayes CJ, Cucciare MA, Martin BC, Hudson TJ, Bush K, Lo-Ciganic W, Yu H, Charron E, Gordon AJ. Using data science to improve outcomes for persons with opioid use disorder. Subst Abus. 2022; 43(1):956-963. PMID: 35420927.
      View in: PubMed
    20. Hayes CJ, Krebs EE, Brown J, Li C, Hudson T, Martin BC. Impact of transitioning from long-term to intermittent opioid therapy on the development of opioid-related adverse outcomes: A retrospective cohort study. Drug Alcohol Depend. 2022 02 01; 231:109236. PMID: 34974270.
      View in: PubMed
    21. Jain N, Phadnis MA, Martin BC, Mehta JL. Potent Antiplatelet Therapy May Reduce Death from Sepsis in Patients on Chronic Dialysis. Am J Cardiol. 2022 01 01; 162:209-211. PMID: 34740395.
      View in: PubMed
    22. Hayes CJ, Krebs EE, Li C, Brown J, Hudson T, Martin BC. Association between discontinuing chronic opioid therapy and newly diagnosed substance use disorders, accidents, self-inflicted injuries and drug overdoses within the prescribers' health care system: a retrospective cohort study. Addiction. 2022 04; 117(4):946-968. PMID: 34514677.
      View in: PubMed
    23. Hayes CJ, Krebs EE, Brown J, Li C, Hudson T, Martin BC. Association Between Pain Intensity and Discontinuing Opioid Therapy or Transitioning to Intermittent Opioid Therapy After Initial Long-Term Opioid Therapy: A Retrospective Cohort Study. J Pain. 2021 12; 22(12):1709-1721. PMID: 34186177.
      View in: PubMed
    24. Chopra D, Li C, Painter JT, Bona JP, Nookaew I, Martin BC. Characteristics and Network Influence of Providers Involved in the Treatment of Patients With Chronic Back, Neck or Joint Pain in Arkansas. J Pain. 2021 12; 22(12):1681-1695. PMID: 34174385.
      View in: PubMed
    25. Hayes CJ, Gressler LE, Hu B, Jones BL, Williams JS, Martin BC. Trajectories of Opioid Coverage After Long-Term Opioid Therapy Initiation Among a National Cohort of US Veterans. J Pain Res. 2021; 14:1745-1762. PMID: 34163232.
      View in: PubMed
    26. Teeter BS, Thannisch MM, Martin BC, Zaller ND, Jones D, Mosley CL, Curran GM. Opioid overdose counseling and prescribing of naloxone in rural community pharmacies: A pilot study. Explor Res Clin Soc Pharm. 2021 Jun; 2. PMID: 35128518.
      View in: PubMed
    27. Teeter BS, Jensen CR, Thomas JL, Martin BC, McElfish PA, Mosley CL, Curran GM. Perceptions of HPV vaccination and pharmacist-physician collaboration models to improve HPV vaccination rates. Explor Res Clin Soc Pharm. 2021 Jun; 2. PMID: 35187525.
      View in: PubMed
    28. Hayes CJ, Krebs EE, Hudson T, Brown J, Li C, Martin BC. Impact of opioid dose escalation on pain intensity: a retrospective cohort study. Pain. 2020 05; 161(5):979-988. PMID: 31917775.
      View in: PubMed
    29. Acharya M, Chopra D, Hayes CJ, Teeter B, Martin BC. Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users. Value Health. 2020 04; 23(4):451-460. PMID: 32327162.
      View in: PubMed
    30. Goudie A, Martin B, Li C, Lewis K, Han X, Kathe N, Wilson JC, Thompson J. Higher Rates of Preventive Health Care With Commercial Insurance Compared With Medicaid: Findings From the Arkansas Health Care Independence "Private Option" Program. Med Care. 2020 02; 58(2):120-127. PMID: 31702590.
      View in: PubMed
    31. Hayes CJ, Krebs EE, Hudson T, Brown J, Li C, Martin BC. Impact of opioid dose escalation on the development of substance use disorders, accidents, self-inflicted injuries, opioid overdoses and alcohol and non-opioid drug-related overdoses: a retrospective cohort study. Addiction. 2020 06; 115(6):1098-1112. PMID: 31944486.
      View in: PubMed
    32. Teeter BS, Mosley C, Thomas JL, Martin B, Jones D, Romero JR, Curran GM. Improving HPV vaccination using implementation strategies in community pharmacies: Pilot study protocol. Res Social Adm Pharm. 2020 03; 16(3):336-341. PMID: 31174950.
      View in: PubMed
    33. Ray-Griffith SL, Chopra D, Stowe ZN, Martin BC. Claims for contraceptive services among young women filling chronic opioid prescriptions. Contraception. 2019 05; 99(5):296-299. PMID: 30763579.
      View in: PubMed
    34. Shah A, Hayes CJ, Lakkad M, Martin BC. Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use. J Gen Intern Med. 2019 08; 34(8):1419-1426. PMID: 30684198.
      View in: PubMed
    35. Freeman PR, Curran GM, Drummond KL, Martin BC, Teeter BS, Bradley K, Schoenberg N, Edlund MJ. Utilization of prescription drug monitoring programs for prescribing and dispensing decisions: Results from a multi-site qualitative study. Res Social Adm Pharm. 2019 06; 15(6):754-760. PMID: 30243575.
      View in: PubMed
    36. Heldenbrand SD, Dayer LE, Martin BC, O'Brien C, Choi AN, Gubbins PO, Hawthorne J, Ramey M, Willis K, Flowers SK. APPE Evaluations are Positively Associated with MMI, Pre-pharmacy GPA and Pharmacy GPA. Am J Pharm Educ. 2018 09; 82(7):6326. PMID: 30323388.
      View in: PubMed
    37. Curran GM, Freeman PR, Martin BC, Teeter BS, Drummond KL, Bradley K, Thannisch MM, Mosley CL, Schoenberg N, Edlund M. Communication between pharmacists and primary care physicians in the midst of a U.S. opioid crisis. Res Social Adm Pharm. 2019 08; 15(8):974-985. PMID: 30170901.
      View in: PubMed
    38. Matthews EE, Li C, Long CR, Narcisse MR, Martin BC, McElfish PA. Sleep deficiency among Native Hawaiian/Pacific Islander, Black, and White Americans and the association with cardiometabolic diseases: analysis of the National Health Interview Survey Data. Sleep Health. 2018 06; 4(3):273-283. PMID: 29776622.
      View in: PubMed
    39. Hudson TJ, Painter JT, Gressler LE, Lu L, Williams JS, Booth BM, Martin BC, Sullivan MD, Edlund MJ. Factors Associated with Opioid Initiation in OEF/OIF/OND Veterans with Traumatic Brain Injury. Pain Med. 2018 04 01; 19(4):774-787. PMID: 29036680.
      View in: PubMed
    40. Brown C, Nevola A, Martin BC. Lack of Impact of the 2009 USPSTF Guidelines on Rates of Mammography Screening. J Womens Health (Larchmt). 2018 07; 27(7):875-884. PMID: 29583065.
      View in: PubMed
    41. Gressler LE, Martin BC, Hudson TJ, Painter JT. Relationship between concomitant benzodiazepine-opioid use and adverse outcomes among US veterans. Pain. 2018 03; 159(3):451-459. PMID: 29189516.
      View in: PubMed
    42. Singh M, Raghavan D, Williams JS, Martin BC, Hudson TJ, Owen RR, Jain N. Prevalence of Chronic Kidney Disease, Thrombotic Cardiovascular Events, and Use of Oral P2Y12 Inhibitors among Veterans. Am J Nephrol. 2018; 47(2):67-71. PMID: 29393120.
      View in: PubMed
    43. Shewale AR, Barnes CL, Fischbach LA, Ounpraseuth ST, Painter JT, Martin BC. Comparative Effectiveness of Intra-Articular Hyaluronic Acid and Corticosteroid Injections on the Time to Surgical Knee Procedures. J Arthroplasty. 2017 12; 32(12):3591-3597.e24. PMID: 28781020.
      View in: PubMed
    44. Shah A, Hayes CJ, Martin BC. Factors Influencing Long-Term Opioid Use Among Opioid Naive Patients: An Examination of Initial Prescription Characteristics and Pain Etiologies. J Pain. 2017 11; 18(11):1374-1383. PMID: 28711636.
      View in: PubMed
    45. Hudson TJ, Painter JT, Martin BC, Austen MA, Williams JS, Fortney JC, Sullivan MD, Edlund MJ. Pharmacoepidemiologic analyses of opioid use among OEF/OIF/OND veterans. Pain. 2017 06; 158(6):1039-1045. PMID: 28195856.
      View in: PubMed
    46. Shewale AR, Barnes CL, Fischbach LA, Ounpraseuth ST, Painter JT, Martin BC. Comparison of Low-, Moderate-, and High-Molecular-Weight Hyaluronic Acid Injections in Delaying Time to Knee Surgery. J Arthroplasty. 2017 10; 32(10):2952-2957.e21. PMID: 28606459.
      View in: PubMed
    47. Dayer LE, Shilling R, Van Valkenburg M, Martin BC, Gubbins PO, Hadden K, Heldenbrand S. Assessing the Medication Adherence App Marketplace From the Health Professional and Consumer Vantage Points. JMIR Mhealth Uhealth. 2017 Apr 19; 5(4):e45. PMID: 28428169.
      View in: PubMed
    48. Shah A, Hayes CJ, Martin BC. Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use - United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017 Mar 17; 66(10):265-269. PMID: 28301454.
      View in: PubMed
    49. Hammond DA, Kathe N, Shah A, Martin BC. Cost-Effectiveness of Histamine2 Receptor Antagonists Versus Proton Pump Inhibitors for Stress Ulcer Prophylaxis in Critically Ill Patients. Pharmacotherapy. 2017 01; 37(1):43-53. PMID: 27809338.
      View in: PubMed
    50. Shewale AR, Fischbach LA, Hammond DA, Martin BC. Letter to the Editor on 'Hyaluronic Acid Injections in Medicare Knee Osteoarthritis Patients Are Associated With Longer Time to Knee Arthroplasty'. J Arthroplasty. 2017 02; 32(2):696-697. PMID: 27780624.
      View in: PubMed
    51. Shah A, Shewale A, Hayes CJ, Martin BC. Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients. Stroke. 2016 06; 47(6):1555-61. PMID: 27103018.
      View in: PubMed
    52. Heldenbrand S, Martin BC, Gubbins PO, Hadden K, Renna C, Shilling R, Dayer L. Assessment of medication adherence app features, functionality, and health literacy level and the creation of a searchable Web-based adherence app resource for health care professionals and patients. J Am Pharm Assoc (2003). 2016 May-Jun; 56(3):293-302. PMID: 27067551.
      View in: PubMed
    53. Martin BC, Hayes C, Austen M, Hudson T. Author response to "Impact of survival bias on opioid-related outcomes when using death as an exclusion criterion". Pharmacoepidemiol Drug Saf. 2016 Apr; 25(4):477-8. PMID: 27059545.
      View in: PubMed
    54. Heldenbrand SD, Flowers SK, Bordelon BJ, Gubbins PO, O'Brien C, Stowe CD, Martin BC. Multiple Mini-Interview Performance Predicts Academic Difficulty in the PharmD Curriculum. Am J Pharm Educ. 2016 Mar 25; 80(2):27. PMID: 27073280.
      View in: PubMed
    55. Dayer L, Harrington S, Martin B. Adherence to Adjuvant Neuropathic Pain Medications in a Palliative Care Clinic. J Palliat Med. 2016 05; 19(5):538-41. PMID: 26835743.
      View in: PubMed
    56. Brown JD, Hutchison LC, Li C, Painter JT, Martin BC. Predictive Validity of the Beers and Screening Tool of Older Persons' Potentially Inappropriate Prescriptions (STOPP) Criteria to Detect Adverse Drug Events, Hospitalizations, and Emergency Department Visits in the United States. J Am Geriatr Soc. 2016 Jan; 64(1):22-30. PMID: 26782849.
      View in: PubMed
    57. Shewale AR, Johnson JT, Li C, Nelsen D, Martin BC. Net Clinical Benefits of Guidelines and Decision Tool Recommendations for Oral Anticoagulant Use among Patients with Atrial Fibrillation. J Stroke Cerebrovasc Dis. 2015 Dec; 24(12):2845-53. PMID: 26482369.
      View in: PubMed
    58. Hayes CJ, Hudson TJ, Phillips MM, Bursac Z, Williams JS, Austin MA, Edlund MJ, Martin BC. The influence of propoxyphene withdrawal on opioid use in veterans. Pharmacoepidemiol Drug Saf. 2015 Nov; 24(11):1180-8. PMID: 26248742.
      View in: PubMed
    59. Patil PR, Wolfe J, Said Q, Thomas J, Martin BC. Opioid use in the management of diabetic peripheral neuropathy (DPN) in a large commercially insured population. Clin J Pain. 2015 May; 31(5):414-24. PMID: 25853725.
      View in: PubMed
    60. Shewale A, Johnson J, Li C, Nelsen D, Martin B. Variation in Anticoagulant Recommendations by the Guidelines and Decision Tools among Patients with Atrial Fibrillation. Healthcare (Basel). 2015 Mar 05; 3(1):130-45. PMID: 27417752.
      View in: PubMed
    61. Ali MM, O'Brien CE, Cleves MA, Martin BC. Exploring the possible association between montelukast and neuropsychiatric events among children with asthma: a matched nested case-control study. Pharmacoepidemiol Drug Saf. 2015 Apr; 24(4):435-45. PMID: 25683909.
      View in: PubMed
    62. Vanderlip ER, Sullivan MD, Edlund MJ, Martin BC, Fortney J, Austen M, Williams JS, Hudson T. National study of discontinuation of long-term opioid therapy among veterans. Pain. 2014 Dec; 155(12):2673-2679. PMID: 25277462.
      View in: PubMed
    63. Edlund MJ, Austen MA, Sullivan MD, Martin BC, Williams JS, Fortney JC, Hudson TJ. Patterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011. Pain. 2014 Nov; 155(11):2337-43. PMID: 25180008.
      View in: PubMed
    64. Edlund MJ, Martin BC, Russo JE, DeVries A, Braden JB, Sullivan MD. The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription. Clin J Pain. 2014 Jul; 30(7):557-64. PMID: 24281273.
      View in: PubMed
    65. Dhamane AD, Martin BC, Brixner DI, Hudson TJ, Said Q. Metabolic monitoring of patients prescribed second-generation antipsychotics. J Psychiatr Pract. 2013 Sep; 19(5):360-74. PMID: 24042242.
      View in: PubMed
    66. Casciano JP, Dotiwala ZJ, Martin BC, Kwong WJ. The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective. J Manag Care Pharm. 2013 May; 19(4):302-16. PMID: 23627576.
      View in: PubMed
    67. Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc (2003). 2013 Mar-Apr; 53(2):172-81. PMID: 23571625.
      View in: PubMed
    68. Kelkar M, Cleves MA, Foster HR, Hogan WR, James LP, Martin BC. Prescription-acquired acetaminophen use and the risk of asthma in adults: a case-control study. Ann Pharmacother. 2012 Dec; 46(12):1598-608. PMID: 23170033.
      View in: PubMed
    69. Bhurke SM, Martin BC, Li C, Franks AM, Bursac Z, Said Q. Effect of the clopidogrel-proton pump inhibitor drug interaction on adverse cardiovascular events in patients with acute coronary syndrome. Pharmacotherapy. 2012 Sep; 32(9):809-18. PMID: 22744772.
      View in: PubMed
    70. Richardson LP, Russo JE, Katon W, McCarty CA, DeVries A, Edlund MJ, Martin BC, Sullivan M. Mental health disorders and long-term opioid use among adolescents and young adults with chronic pain. J Adolesc Health. 2012 Jun; 50(6):553-8. PMID: 22626480.
      View in: PubMed
    71. Said Q, Martin BC, Joish VN, Kreilick C, Mathai SC. The cost to managed care of managing pulmonary hypertension. J Med Econ. 2012; 15(3):500-8. PMID: 22313330.
      View in: PubMed
    72. Gokhale M, Martin BC. Prescription-acquired acetaminophen use and potential overuse patterns: 2001-2008. Pharmacoepidemiol Drug Saf. 2012 Feb; 21(2):226-30. PMID: 21915939.
      View in: PubMed
    73. Martin BC, Fan MY, Edlund MJ, Devries A, Braden JB, Sullivan MD. Long-term chronic opioid therapy discontinuation rates from the TROUP study. J Gen Intern Med. 2011 Dec; 26(12):1450-7. PMID: 21751058.
      View in: PubMed
    74. Richardson LP, Fan MY, McCarty CA, Katon W, Edlund M, DeVries A, Martin BC, Sullivan M. Trends in the prescription of opioids for adolescents with non-cancer pain. Gen Hosp Psychiatry. 2011 Sep-Oct; 33(5):423-8. PMID: 21749839.
      View in: PubMed
    75. Domino ME, Martin BC, Wiley-Exley E, Richards S, Henson A, Carey TS, Sleath B. Increasing time costs and copayments for prescription drugs: an analysis of policy changes in a complex environment. Health Serv Res. 2011 Jun; 46(3):900-19. PMID: 21306363.
      View in: PubMed
    76. Li C, Martin BC. Trends in emergency department visits attributable to acetaminophen overdoses in the United States: 1993-2007. Pharmacoepidemiol Drug Saf. 2011 Aug; 20(8):810-8. PMID: 21796717.
      View in: PubMed
    77. Braden JB, Russo J, Fan MY, Edlund MJ, Martin BC, DeVries A, Sullivan MD. Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med. 2010 Sep 13; 170(16):1425-32. PMID: 20837827.
      View in: PubMed
    78. Edlund MJ, Martin BC, Fan MY, Devries A, Braden JB, Sullivan MD. Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. Drug Alcohol Depend. 2010 Nov 01; 112(1-2):90-8. PMID: 20634006.
      View in: PubMed
    79. Edlund MJ, Martin BC, Fan MY, Braden JB, Devries A, Sullivan MD. An analysis of heavy utilizers of opioids for chronic noncancer pain in the TROUP study. J Pain Symptom Manage. 2010 Aug; 40(2):279-89. PMID: 20579834.
      View in: PubMed
    80. Sullivan MD, Edlund MJ, Fan MY, DeVries A, Braden JB, Martin BC. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study. Pain. 2010 Aug; 150(2):332-339. PMID: 20554392.
      View in: PubMed
    81. Pathak P, West D, Martin BC, Helm ME, Henderson C. Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005. Psychiatr Serv. 2010 Feb; 61(2):123-9. PMID: 20123816.
      View in: PubMed
    82. Edlund MJ, Martin BC, Devries A, Fan MY, Braden JB, Sullivan MD. Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain. 2010 Jan; 26(1):1-8. PMID: 20026946.
      View in: PubMed
    83. Sleath B, Domino ME, Wiley-Exley E, Martin B, Richards S, Carey T. Antidepressant and antipsychotic use and adherence among Medicaid youths: differences by race. Community Ment Health J. 2010 Jun; 46(3):265-72. PMID: 20091226.
      View in: PubMed
    84. Thielke SM, Simoni-Wastila L, Edlund MJ, DeVries A, Martin BC, Braden JB, Fan MY, Sullivan MD. Age and sex trends in long-term opioid use in two large American health systems between 2000 and 2005. Pain Med. 2010 Feb; 11(2):248-56. PMID: 20002323.
      View in: PubMed
    85. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin. 2009 Sep; 25(9):2303-10. PMID: 19635045.
      View in: PubMed
    86. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Prospective validation of eight different adherence measures for use with administrative claims data among patients with schizophrenia. Value Health. 2009 Sep; 12(6):989-95. PMID: 19402852.
      View in: PubMed
    87. Martin BC, Church TS, Bonnell R, Ben-Joseph R, Borgstadt T. The impact of overweight and obesity on the direct medical costs of truck drivers. J Occup Environ Med. 2009 Feb; 51(2):180-4. PMID: 19209039.
      View in: PubMed
    88. Martin BC, Wiley-Exley EK, Richards S, Domino ME, Carey TS, Sleath BL. Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother. 2009 Jan; 43(1):36-44. PMID: 19126828.
      View in: PubMed
    89. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care. 2008 Nov; 46(11):1125-33. PMID: 18953222.
      View in: PubMed
    90. Braden JB, Fan MY, Edlund MJ, Martin BC, DeVries A, Sullivan MD. Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study. J Pain. 2008 Nov; 9(11):1026-35. PMID: 18676205.
      View in: PubMed
    91. Sullivan MD, Edlund MJ, Fan MY, DeVries A, Braden JB, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study. Pain. 2008 Aug 31; 138(2):440-449. PMID: 18547726.
      View in: PubMed
    92. Chen H, Kennedy WK, Dorfman JH, Fincham JE, Reeves J, Martin BC. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia. Curr Med Res Opin. 2007 Jun; 23(6):1351-65. PMID: 17559734.
      View in: PubMed
    93. Gold DT, Martin BC, Frytak JR, Amonkar MM, Cosman F. A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis. Curr Med Res Opin. 2007 Mar; 23(3):585-94. PMID: 17355739.
      View in: PubMed
    94. Martin BC, Barghout V, Cerulli A. Direct medical costs of constipation in the United States. Manag Care Interface. 2006 Dec; 19(12):43-9. PMID: 17274481.
      View in: PubMed
    95. Chen H, Reeves JH, Fincham JE, Kennedy WK, Dorfman JH, Martin BC. Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia medicaid enrollees in 2001. J Clin Psychiatry. 2006 Jun; 67(6):972-82. PMID: 16848658.
      View in: PubMed
    96. Chen H, Deshpande AD, Jiang R, Martin BC. An epidemiological investigation of off-label anticonvulsant drug use in the Georgia Medicaid population. Pharmacoepidemiol Drug Saf. 2005 Sep; 14(9):629-38. PMID: 15597329.
      View in: PubMed
    97. Sapra S, Nielsen K, Martin BC. The net cost of asthma to North Carolina Medicaid and the influence of comorbidities that drive asthma costs. J Asthma. 2005 Jul-Aug; 42(6):469-77. PMID: 16293542.
      View in: PubMed
    98. Cook CL, Wade WE, Martin BC, Perri M. Concordance among three self-reported measures of medication adherence and pharmacy refill records. J Am Pharm Assoc (2003). 2005 Mar-Apr; 45(2):151-9. PMID: 15868757.
      View in: PubMed
    99. Ganguly R, Kotzan JA, Miller LS, Kennedy K, Martin BC. Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000. J Clin Psychiatry. 2004 Oct; 65(10):1377-88. PMID: 15491242.
      View in: PubMed
    100. Miller LS, Martin BC. Current and future forecasts of service use and expenditures of Medicaid-eligible schizophrenia patients in the state of Georgia. Schizophr Bull. 2004; 30(4):983-95. PMID: 15954202.
      View in: PubMed
    101. Ganguly R, Miller LS, Martin BC. Future employability, a new approach to cost-effectiveness analysis of antipsychotic therapy. Schizophr Res. 2003 Sep 01; 63(1-2):111-9. PMID: 12892865.
      View in: PubMed
    102. Martin BC, Ganguly R, Pannicker S, Frech F, Barghout V. Utilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome. Curr Med Res Opin. 2003; 19(8):771-80. PMID: 14687449.
      View in: PubMed
    103. Nerurkar J, Wade WE, Martin BC. Cost/death averted with venous thromboembolism prophylaxis in patients undergoing total knee replacement or knee arthroplasty. Pharmacotherapy. 2002 Aug; 22(8):990-1000. PMID: 12173802.
      View in: PubMed
    104. Cantrell R, Young AF, Martin BC. Antibiotic prescribing in ambulatory care settings for adults with colds, upper respiratory tract infections, and bronchitis. Clin Ther. 2002 Jan; 24(1):170-82. PMID: 11833830.
      View in: PubMed
    Martin's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (323) concept(s)
    _
    Co-Authors Expand Description
    See all (49) people
    _
    Similar People Expand Description
    See all (35) people
    _
    Same Department Expand Description
    Search Department